Jafron Biomedical Co.,Ltd. (SHE:300529)
China · Delayed Price · Currency is CNY 18.98
+0.19 (1.01%)
At close: Mar 6, 2026
Jafron Biomedical Market Cap
Jafron Biomedical has a market cap or net worth of 14.7 billion as of March 6, 2026. Its market cap has decreased by -29.96% in one year.
Market Cap
14.70B
Enterprise Value
13.64B
Revenue
2.04B
Ranking
n/a
PE Ratio
30.15
Stock Price
18.98
Market Cap Chart
Since August 2, 2016, Jafron Biomedical's market cap has increased from 6.41B to 14.70B, an increase of 129.41%. That is a compound annual growth rate of 9.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 14.70B | -3.51% |
| Dec 31, 2025 | 15.23B | -32.96% |
| Dec 31, 2024 | 22.72B | 27.96% |
| Dec 29, 2023 | 17.76B | -28.23% |
| Dec 30, 2022 | 24.74B | -42.00% |
| Dec 31, 2021 | 42.65B | -21.30% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Aug 2, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Autobio Diagnostics | 19.66B |
| Double Medical Technology | 18.43B |
| MeHow Innovative | 16.39B |
| Shandong Weigao Blood Purification Products | 16.20B |
| Beijing Balance Medical Technology | 13.88B |
| Shanghai MicroPort Endovascular MedTech | 13.12B |
| Cofoe Medical Technology | 11.84B |
| Shandong Weigao Orthopaedic Device | 11.41B |